4-(Methylsulfonyl)phenylacetic Asid CAS 90536-66-6 Pite> 99.5% (HPLC) Etoricoxib Entèmedyè Faktori
Dirijan manifakti ak founisè, entèmedyè nan Etoricoxib
Etoricoxib API CAS 202409-33-4
4-(Methylthio) Asid fenilasetik CAS 16188-55-9
4-(Methylsulfonyl) asid fenilasetik CAS 90536-66-6
Please contact: alvin@ruifuchem.com
Non Chimik | 4-(Methylsulfonyl)phenylacetic asid |
Sinonim | 4-Methylsulphonylphenylacetic Asid;4-(Methanesulfonyl) asid fenilasetik;(4-Methanesulfonylphenyl) asid acetic;4-Methylsulfonyl Phenyl Acetic Asid;2-(4-(Methylsulfonyl)phenyl)acetic asid;[p-(Methylsulfonyl)phenyl]-Acetic Asid;4-Mesylphenylacetic asid |
Nimewo CAS | 90536-66-6 |
Nimewo CAT | RF-PI1182 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C9H10O4S |
Pwa molekilè | 214.24 |
Pwen k ap fonn | 136.0 a 140.0 ℃ |
Dansite | 1.35 |
Solibilite | Soluble nan metanol |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Blan blan poud solid |
Pite / Metòd analiz | >99.5% (HPLC) |
Pwen k ap fonn | 136.0 a 140.0 ℃ |
Imidite (KF) | <0.50% |
Single pi gwo enpurte | <0.30% |
Enpurte total | <0.50% |
Enfrawouj Spectrum | Konfòm ak estrikti |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Etoricoxib (CAS: 202409-33-4) |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
![1](https://a395.goodao.net/uploads/15.jpg)
![www.ruifuchem.com](https://a395.goodao.net/uploads/Pregabalin-CAS-148553-50-8-Factory-Shanghai-Ruifu-Chemical-Co.-Ltd.-www.ruifuchemical.com_.png)
4-(Methylsulfonyl)phenylacetic Acid (CAS: 90536-66-6) se yon entèmedyè nan Etoricoxib (CAS: 202409-33-4).Etoricoxib se yon kalite trè selektif cyclooxygenase-2 (COX-2) inhibiteurs devlope pa konpayi an Merck.Etoricoxib se lajman ki itilize nan tretman osteoartrit (OA), atrit rimatoyid, spondilit ankylosing, doulè nan do kwonik ki ba, atrit gouty egi, dysmenorrhea prensipal ak doulè apre operasyon, ak lòt maladi.Etoricoxib, yon inibitè COX-2 selektif, gen efè anti-enflamatwa, analgesic ak antipiretik, apwopriye pou tretman sentòm ak siy ostoartrit egi ak kwonik, osi byen ke atrit gouty egi.Etoricoxib absòbe rapidman, ak yon byodisponibilite oral 80 a 100%, epi li rive nan maksimòm konsantrasyon plasma nan 1 a 2 èdtan apre dòz la.Manje diminye vitès la nan absòpsyon men pa gen okenn efè sou limit la nan absòpsyon.Li montre yon mwatye lavi eliminasyon ki long apeprè 22 èdtan, ki montre farmakokinetik lineyè plasma san akimilasyon pandan plizyè dòz.